Scabies therapy update: Should 25% benzyl benzoate emulsion be reconsidered as a first-line agent in classical scabies?
Br J Dermatol
.
2024 Mar 15;190(4):459-460.
doi: 10.1093/bjd/ljae016.
Authors
Lucinda Claire Fuller
1
,
Cord Sunderkötter
2
Affiliations
1
International Alliance for the Control of Scabies (IACS), London Bridge Hospital, London, UK.
2
Department of Dermatology and Venereology, University Hospital Halle, Martin-Luther-University Halle-Wittenberg, Germany.
PMID:
38234049
DOI:
10.1093/bjd/ljae016
No abstract available
Publication types
Editorial
Comment
MeSH terms
Benzoates / adverse effects
Emulsions
Humans
Permethrin*
Scabies* / drug therapy
Substances
Permethrin
benzyl benzoate
Emulsions
Benzoates